Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-16 4:19 pm Sale | 13D | Aptinyx Inc. APTX | Longitude Capital Partners II LLC | 192,805 0.3% | -3,451,746 (-94.71%) | View |
| 2023-02-14 4:31 pm Purchase | 13D | Aptinyx Inc. APTX | Longitude Capital Partners II LLC | 3,644,551 5.4% | 137,807 (+3.93%) | View |
| 2023-02-10 7:21 pm Unchanged | 13G | Aptinyx Inc. APTX | Artal International S.C.A. | 6,116,493 9% | 0 (Unchanged) | View |
| 2023-01-20 10:42 am Purchase | 13G | Aptinyx Inc. APTX | Kryzanowski John A | 6,637,800 9.8% | 746,998 (+12.68%) | View |
| 2022-06-24 2:33 pm Purchase | 13G | Aptinyx Inc. APTX | Kryzanowski John A | 5,890,802 8.7% | 3,948,122 (+203.23%) | View |
| 2022-06-24 2:22 pm Sale | 13G | Aptinyx Inc. APTX | Kryzanowski John A | 1,942,680 5.77% | -2,753,120 (-58.63%) | View |
| 2022-06-24 1:13 pm Purchase | 13G | Aptinyx Inc. APTX | Kryzanowski John A | 4,695,800 7.42% | 2,914,509 (+163.62%) | View |
| 2022-06-24 11:56 am Purchase | 13G | Aptinyx Inc. APTX | Kryzanowski John A | 1,781,291 5.1% | 1,781,291 (New Position) | View |
| 2022-02-11 4:42 pm Unchanged | 13D | Aptinyx Inc. APTX | New Leaf Ventures III L.P. | 3,290,079 4.9% | 0 (Unchanged) | View |
| 2021-05-04 12:31 pm Purchase | 13D | Aptinyx Inc. APTX | Frazier Life Sciences VIII L.P. | 3,195,055 4.8% | 4,976 (+0.16%) | View |
| 2021-03-26 4:16 pm Unchanged | 13D | Aptinyx Inc. APTX | Bain Capital Life Sciences Fund L.P. | 8,066,113 12.1% | 0 (Unchanged) | View |
| 2021-02-04 4:37 pm Sale | 13D | Aptinyx Inc. APTX | Frazier Life Sciences VIII L.P. | 3,190,079 5.1% | -50,037 (-1.54%) | View |
| 2021-01-29 4:16 pm Purchase | 13G | Aptinyx Inc. APTX | Artal International S.C.A. | 6,116,493 9.7% | 6,116,493 (New Position) | View |
| 2020-10-27 4:23 pm Purchase | 13D | Aptinyx Inc. APTX | Bain Capital Life Sciences Fund L.P. | 8,066,113 13.3% | 3,023,816 (+59.97%) | View |
| 2020-02-14 4:05 pm Sale | 13G | Aptinyx Inc. APTX | PFM Health Sciences LP | 0 0% | -1,910,972 (Position Closed) | View |
| 2020-02-12 5:55 pm Unchanged | 13D | Aptinyx Inc. APTX | New Leaf Ventures III L.P. | 3,290,079 7.5% | 0 (Unchanged) | View |
| 2020-02-12 4:34 pm Purchase | 13D | Aptinyx Inc. APTX | Longitude Capital Partners II LLC | 3,506,744 8% | 316,665 (+9.93%) | View |
| 2020-01-17 3:53 pm Purchase | 13D | Aptinyx Inc. APTX | ADAMS STREET PARTNERS LLC | 5,030,628 11.5% | 5,030,628 (New Position) | View |
| 2020-01-16 4:19 pm Purchase | 13D | Aptinyx Inc. APTX | Bain Capital Life Sciences Fund L.P. | 5,042,297 11.1% | 3,023,816 (+149.81%) | View |
| 2020-01-16 1:19 pm Purchase | 13D | Aptinyx Inc. APTX | Frazier Life Sciences VIII L.P. | 3,240,116 7.1% | 50,037 (+1.57%) | View |